当前位置:首页 - 行情中心 - 鲁抗医药(600789) - 财务分析 - 资产负债表

鲁抗医药

(600789)

  

流通市值:90.95亿  总市值:90.95亿
流通股本:8.99亿   总股本:8.99亿

资产负债表

报告期2024-12-312024-09-302024-06-302024-03-31
公司类型通用通用通用通用
流动资产:
货币资金772,536,945.22908,214,646.54787,776,748.09899,286,158.63
应收票据及应收账款940,440,122.12873,993,894.97943,641,495.81,027,986,975.85
应收账款940,440,122.12873,993,894.97943,641,495.81,027,986,975.85
应收款项融资496,587,244.23646,380,420.76510,774,939.78449,948,197.6
预付款项49,730,071.377,235,467.5372,298,440.3499,380,001.97
其他应收款合计354,780,622.27352,564,754.11346,292,310.6130,944,652.13
存货1,484,208,209.111,317,991,495.871,224,338,542.661,203,817,617.14
其他流动资产30,798,429.3725,721,856.3421,350,347.2226,988,751.51
流动资产平衡项目0000
流动资产合计4,130,301,803.624,203,339,916.123,907,510,944.53,739,471,654.83
非流动资产:
长期应收款-00176,411,648.89
长期股权投资70,196,407.6871,956,782.0273,991,963.4776,097,209.74
其他权益工具投资17,804,315.9922,825,209.2722,825,209.2725,256,557.91
投资性房地产41,542,566.3252,112,743.2152,307,674.1451,494,249.82
固定资产3,710,666,844.93,652,318,882.143,694,117,012.983,690,212,799.89
在建工程121,858,867.39177,758,224.47123,229,703.74181,655,464.03
无形资产766,203,266.06722,830,758.69722,942,218.42716,796,539.47
开发支出127,280,307.33135,359,658.16116,018,401.49115,467,188.73
长期待摊费用1,121,634.11632,880.61694,127.11810,497.37
递延所得税资产24,026,545.7830,656,966.423,118,730.8530,774,013.82
其他非流动资产86,982,317.2480,246,974.06106,575,387.12110,458,984.49
非流动资产平衡项目0000
非流动资产合计4,967,683,072.84,946,699,079.034,935,820,428.595,175,435,154.16
资产平衡项目0000
资产总计9,097,984,876.429,150,038,995.158,843,331,373.098,914,906,808.99
流动负债:
短期借款871,771,193.79759,339,913.32781,964,791.55801,433,683.34
应付票据及应付账款1,502,685,721.711,689,977,067.281,425,750,394.091,490,387,061.21
其中:应付票据602,428,121.69838,948,931.28575,669,975.9538,640,680
应付账款900,257,600.02851,028,136850,080,418.19951,746,381.21
预收款项-00-
合同负债104,655,572.3889,572,030.8976,834,718.03115,300,943.11
应付职工薪酬16,442,255.8422,405,799.2819,680,517.119,866,220.27
应交税费21,829,493.1624,661,700.529,404,879.4935,804,025.76
其他应付款合计250,539,831.37204,427,930.8257,139,463.06299,382,510.27
应付股利1,680,905.491,680,905.491,680,905.491,680,905.49
一年内到期的非流动负债282,557,078.4678,968,254.37628,325,035.75662,335,255.28
其他流动负债10,450,921.9721,107,081.6332,057,253.6542,929,980.02
流动负债平衡项目0000
流动负债合计3,060,932,068.623,490,459,778.073,251,157,052.723,467,439,679.26
非流动负债:
长期借款1,685,900,0001,362,826,0001,335,376,0001,363,926,000
长期应付款123,857,705123,857,705123,857,705123,857,705
递延收益165,724,728.06139,911,883.43143,468,664.05147,025,444.67
非流动负债平衡项目0000
非流动负债合计1,975,482,433.061,626,595,588.431,602,702,369.051,634,809,149.67
负债平衡项目0000
负债合计5,036,414,501.685,117,055,366.54,853,859,421.775,102,248,828.93
所有者权益(或股东权益):
实收资本(或股本)898,669,632898,669,632897,162,662896,055,624
资本公积1,698,137,293.881,698,137,293.881,689,765,625.491,683,516,845.74
其他综合收益-22,195,684.01-17,174,790.73-17,174,790.73-14,743,442.09
专项储备1,140,010.53987,284.94832,063.51673,063.51
盈余公积207,388,115.67178,378,793.5178,378,793.5178,378,793.5
未分配利润1,135,045,846.281,134,471,263.961,104,105,876.33935,464,589.41
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计3,918,185,214.353,893,469,477.553,853,070,230.13,679,345,474.07
少数股东权益143,385,160.39139,514,151.1136,401,721.22133,312,505.99
股东权益平衡项目0000
股东权益合计4,061,570,374.744,032,983,628.653,989,471,951.323,812,657,980.06
负债和股东权益合计9,097,984,876.429,150,038,995.158,843,331,373.098,914,906,808.99
公告日期2025-03-222024-10-302024-08-222024-04-24
审计意见(境内)标准无保留意见
TOP↑